Speakers:
Jessica Williams, MD, FAAP, D-ABOM has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Jessica Williams, MD, FAAP, D-ABOM has indicated the presentation may include discussion of any off-label uses of a product.
Explanation Given: medications for pediatric obesity often include off label choices: metformin, lisdexamfetamine, phentermine monotherapy, topamax monotherapy
Planners and other Administrative Support:
Katherine Joy, BA, Erin Foley, AA, and Kenneth Spiegelman, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
“Connecticut Children’s is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Connecticut Children's designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only credits commensurate with the extent of their participation in the various activities. • Conflict of Interest Policy: All faculty participating in Continuing Medical Education activities sponsored by Connecticut Children’s are required to disclose to the program audience any actual or perceived conflict of interest related to the content of their presentation. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content. The planners, activity director and speaker(s) do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
Dr. Jessica Williams has indicated the presentation may include discussion of off-label uses of a product. Explanation Given: medications for pediatric obesity often include off label choices: metformin, lisdexamfetamine, phentermine monotherapy, topamax monotherapy.